148 related articles for article (PubMed ID: 6268598)
1. Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Fu KP; Neu HC
J Antimicrob Chemother; 1981 Mar; 7(3):287-92. PubMed ID: 6268598
[No Abstract] [Full Text] [Related]
2. Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
Neu HC; Fu KP
Antimicrob Agents Chemother; 1980 Oct; 18(4):582-5. PubMed ID: 6255862
[TBL] [Abstract][Full Text] [Related]
3. Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.
Crosby MA; Gump DW
Antimicrob Agents Chemother; 1982 Sep; 22(3):398-405. PubMed ID: 6291451
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae.
Yu PK; Washington JA
Antimicrob Agents Chemother; 1981 Jul; 20(1):63-5. PubMed ID: 6269484
[TBL] [Abstract][Full Text] [Related]
5. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
[TBL] [Abstract][Full Text] [Related]
6. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Fuchs PC; Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1987 Sep; 8(1):61-5. PubMed ID: 3501975
[TBL] [Abstract][Full Text] [Related]
7. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
Piddock LJ; Jin YF; Turner HL
J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
[TBL] [Abstract][Full Text] [Related]
8. Evolution of beta-lactamase inhibitors.
Rolinson GN
Rev Infect Dis; 1991; 13 Suppl 9():S727-32. PubMed ID: 1656513
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor.
Niwa T; Yoshida T; Tamura A; Kazuno Y; Inouye S; Ito T; Kojima M
J Antibiot (Tokyo); 1986 Jul; 39(7):943-55. PubMed ID: 3019978
[TBL] [Abstract][Full Text] [Related]
10. 'Beta-lactams' as beta-lactamase inhibitors.
Cole M
Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):207-23. PubMed ID: 6109317
[TBL] [Abstract][Full Text] [Related]
11. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
12. The effect of inhibitors of beta-lactamases on beta-lactamase extracts and on intact cells.
Li JT; Moosdeen F; Williams JD
J Antimicrob Chemother; 1982 Apr; 9(4):287-96. PubMed ID: 6282800
[No Abstract] [Full Text] [Related]
13. Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase.
Easton CJ; Knowles JR
Antimicrob Agents Chemother; 1984 Sep; 26(3):358-63. PubMed ID: 6095753
[TBL] [Abstract][Full Text] [Related]
14. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
Aldridge KE; Sanders CV; Marier RL
J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of cefodizime (HR-221) in combination with beta-lactamase inhibitors.
Segatore B; Perilli M; Franceschini N; Setacci D; Oratore A; Amicosante G
J Chemother; 1993 Jun; 5(3):147-50. PubMed ID: 8396624
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
Neu HC
Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
[TBL] [Abstract][Full Text] [Related]
17. Beta-lactamase inactivation by mechanism-based reagents.
Fisher J; Belasco JG; Charnas RL; Khosla S; Knowles JR
Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):309-19. PubMed ID: 6109326
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
Mohanty S; Singhal R; Sood S; Dhawan B; Das BK; Kapil A
Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
Kuo HY; Wang FD; Yen YF; Lin ML; Liu CY
New Microbiol; 2009 Jan; 32(1):49-55. PubMed ID: 19382669
[TBL] [Abstract][Full Text] [Related]
20. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
